Biocon can still work with Pfizer, says Kiran Mazumdar Shaw - Hindu Business Line


Hindu Business Line
Biocon can still work with Pfizer, says Kiran Mazumdar Shaw
Hindu Business Line
Weeks after its $350-million marketing deal with Pfizer to sell its insulin products globally was called off, Biocon said it was still interested in partnering with the MNC in other areas. The over Rs 2000-crore Biocon, which is India's largest ...
I-bank Espirito Santo concerned at Biocon's accounting processes Business Standard

all 2 news articles »

continue reading

Abbott, Biocon plan nutrition products in India - MarketWatch


Firstpost
Abbott, Biocon plan nutrition products in India
MarketWatch
By Rumman Ahmed BANGALORE (MarketWatch) -- Abbott Laboratories (NYSE:ABT) has tied up with a unit of India's Biocon Ltd. to develop nutrition products, as the US drug maker looks to tap into the opportunity from the problems of malnutrition and ...
Abbott Ties Up With Biocon Unit To Develop Nutrition Products In India Fox Business
Abbott, Biocon arm to develop nutrition products Business Standard
Abbott, Biocon to develop nutrition products for India NDTV
Economic Times - PR Newswire (press release)
all 56 news articles »

continue reading

Biocon Tops Forecast, Shares Jump - Wall Street Journal

Biocon Tops Forecast, Shares Jump
Wall Street Journal
By RUMMAN AHMED BANGALORE -- Biocon Ltd., India's largest biotechnology company by revenue, Friday beat analysts' expectations despite a 3.0% drop in fourth-quarter consolidated net profit on the back of a jump in other operating income.
Biocon Q4 beats forecast, shares rise Reuters India
Biocon revenue rises 16%, net profit hit by loss of licensing revenue Livemint
Biocon Q4 net profit down 3%, shares rise Hindustan Times
Financial Express - Hindu Business Line
all 15 news articles »

continue reading

Biocon logs smart recovery in fourth quarter - Economic Times

Biocon logs smart recovery in fourth quarter
Economic Times
Biotech major Biocon logged a smart recovery in its fourth quarter performance. After the divestment of Axicorp and the snapping of its biosimilar insulin deal with Pfizer, the company was expected to post a subdued performance.

continue reading

Biocon quarterly net profit declines 29 percent - New York Daily News


RTT News
Biocon quarterly net profit declines 29 percent
New York Daily News
New Delhi, April 27 — Biopharma company Biocon Friday reported a 29 percent decline in net profit at Rs.62.34 crore for the quarter ended March 31 against Rs.88 crore during the like period of the previous financial year. The total income stood at ...
Biocon Q4 Indian GAAP Profit Dips RTT News
Biocon net drops on loss of licensing revenue; sales up 16% Livemint
Biocon beats estimates but net down 3% Business Standard
Moneycontrol.com - The Hindu - Indian Express
all 45 news articles »

continue reading

Abbott Ties Up With Biocon Unit To Develop Nutrition Products In India - Wall Street Journal


Moneycontrol.com
Abbott Ties Up With Biocon Unit To Develop Nutrition Products In India
Wall Street Journal
By Rumman Ahmed BANGALORE (Dow Jones)--Abbott Laboratories (ABT) has tied up with a unit of India's Biocon Ltd. (532523.BY) to develop nutrition products, as the US drug maker looks to tap into the opportunity from the problems of malnutrition and ...
Abbott, Biocon to develop nutrition products for India Reuters India
Abbott to set up nutrition R&D centre with Biocon unit Moneycontrol.com
Abbott, Syngene To Open First Nutrition R&D Center In India Asian Scientist Magazine
domain-B
all 10 news articles »

continue reading

US cancer institute explores joint research with Biocon - Hindu Business Line

continue reading